TREATMENT OF PRIMARY BREAST-CANCER WITH CHEMOTHERAPY AND TAMOXIFEN

被引:259
作者
FISHER, B
REDMOND, C
BROWN, A
WOLMARK, N
WITTLIFF, J
FISHER, ER
PLOTKIN, D
BOWMAN, D
SACHS, S
WOLTER, J
FRELICK, R
DESSER, R
LICALZI, N
GEGGIE, P
CAMPBELL, T
ELIAS, EG
PRAGER, D
KOONTZ, P
VOLK, H
DIMITROV, N
GARDNER, B
LERNER, H
SHIBATA, H
机构
关键词
D O I
10.1056/NEJM198107023050101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1 / 6
页数:6
相关论文
共 13 条
[1]  
ALLEGRA JC, 1979, ADJUVANT THERAPY CAN, V2, P47
[2]   NEW ANTI-OESTROGENIC AGENT IN LATE BREAST CANCER - EARLY CLINICAL APPRAISAL OF ICI46474 [J].
COLE, MP ;
JONES, CTA ;
TODD, IDH .
BRITISH JOURNAL OF CANCER, 1971, 25 (02) :270-&
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]  
CUTLER SJ, 1958, J CHRON DIS, V8, P699
[5]   1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].
FISHER, B ;
CARBONE, P ;
ECONOMOU, SG ;
FRELICK, R ;
GLASS, A ;
LERNER, H ;
REDMOND, C ;
ZELEN, M ;
BAND, P ;
KATRYCH, DL ;
WOLMARK, N ;
FISHER, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122
[6]  
GLASS A, CANCER TREAT REP
[7]  
KNIGHT WA, 1977, CANCER RES, V37, P4669
[8]  
LERNER HJ, 1976, CANCER TREAT REP, V60, P1431
[9]   RELATION BETWEEN ESTROGEN RECEPTORS AND RESPONSE RATE TO CYTOTOXIC CHEMOTHERAPY IN METASTATIC BREAST-CANCER [J].
LIPPMAN, ME ;
ALLEGRA, JC ;
THOMPSON, EB ;
SIMON, R ;
BARLOCK, A ;
GREEN, L ;
HUFF, KK ;
DO, HMT ;
AITKEN, SC ;
WARREN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (22) :1223-1228
[10]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163